InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,446.68
(
-1.37%
)
US TECH 100
18,286.80
(
-2.95%
)
Dow Jones
40,347.97
(
-1.21%
)
Brent Oil
79.75
(
-0.28%
)
Bitcoin
63,918.44
(
-2.19%
)
Post# of 5468
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Preciouslife1

Send PM Follow Ignore
Followers 89
Posts 19238
Boards Moderated 4
Alias Born 11/05/2005

Preciouslife1

Re: None

Thursday, 12/30/2021 10:01:52 AM

Thursday, December 30, 2021 10:01:52 AM

Post# of 5468
Lenzilumab, might be the best Covid drug period. And it treats newly hospitalized patients. There are literally zero effective drugs currently authorized for newly hospitalized patients.

The ACTIV-5 trial will prove lenz's worth. The primary endpoint in the ACTIV-5 is for patients with CRP<150mg/L and <85yo. That group represented 336 of 479 patients in the LIVE-AIR trial. That group had 196% efficacy in the LIVE-AIR trial for a p value of 0.0003. That efficacy will be replicated in the ACTIV-5 because GM-CSF is the key to treating Covid.

https://www.bbc.com/news/health-56352128

Bull-markets are born on pessimism, grow on skepticism, mature on optimism and die on euphoria .. Sir John Templeton
Make your Life a Mission .... NOT an Intermission. † §|PL1|§

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up